SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-21-000140
Filing Date
2021-03-05
Accepted
2021-03-05 08:49:43
Documents
2
Period of Report
2021-03-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 03-03-2021 form_8-k.htm 8-K 11520
2 GRAPHIC angiosoma_logo.jpg GRAPHIC 10351
  Complete submission text file 0001161697-21-000140.txt   27170
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 21716651
SIC: 2834 Pharmaceutical Preparations